- Previous Close
3,250.00 - Open
3,300.00 - Bid 3,100.00 x --
- Ask 3,300.00 x --
- Day's Range
3,110.00 - 3,300.00 - 52 Week Range
2,977.00 - 5,100.00 - Volume
4,279 - Avg. Volume
7,147 - Market Cap (intraday)
167.029M - Beta (5Y Monthly) 0.39
- PE Ratio (TTM)
20.92 - EPS (TTM)
1.53 - Earnings Date Mar 24, 2025 - Mar 28, 2025
- Forward Dividend & Yield 1.55 (4.77%)
- Ex-Dividend Date Nov 7, 2024
- 1y Target Est
5,100.00
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. It also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
www.bioventix.comRecent News: BVXP.L
View MorePerformance Overview: BVXP.L
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BVXP.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BVXP.L
View MoreValuation Measures
Market Cap
169.64M
Enterprise Value
163.64M
Trailing P/E
21.26
Forward P/E
19.01
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.65
Price/Book (mrq)
14.13
Enterprise Value/Revenue
12.03
Enterprise Value/EBITDA
15.24
Financial Highlights
Profitability and Income Statement
Profit Margin
59.51%
Return on Assets (ttm)
49.17%
Return on Equity (ttm)
67.29%
Revenue (ttm)
13.61M
Net Income Avi to Common (ttm)
8.1M
Diluted EPS (ttm)
1.53
Balance Sheet and Cash Flow
Total Cash (mrq)
6M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
6.91M